Regenerative Cell Therapy FDA Status: What's Approved and What Isn't

"Regenerative cell therapy" is a broad phrase. People use it for many products and procedures that involve cells, tissues, or substances taken from cells. It is not one single treatment. Stem cells, exosomes, amniotic products, and Wharton's jelly products are all described this way, and each has a different regulatory picture.

In plain terms, the FDA approves or licenses a medical product for specific uses after reviewing it. Some cell-based products, such as certain blood-forming stem cell products made from cord blood, have FDA approval for specific uses. In contrast, most stem cell, exosome, Wharton's jelly, and amniotic products marketed for joints, pain, aesthetics, or anti-aging are NOT FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products.

You may also see products labeled "research use only" (RUO). RUO products are not FDA-approved for human treatment and cannot legally be marketed for that purpose. Also, marketing language can be confusing. A product described as containing stem cells may have been processed in a way that leaves no living cells. None of these products should be called a cure, and none should be promised to regrow tissue.

Traditionally, medicine has approached many joint, pain, and skin concerns with well-established options. These can include movement and physical therapy, lifestyle changes, medications, and procedures. Which of these fit a person is a decision for a licensed clinician.

Regenerative medicine is an active area of scientific research. Researchers study how cells and cell-derived materials behave in the body. Studying something is not the same as proving it works or is safe for a given use, and research findings do not equal FDA approval.

Because the field is changing, rules and guidance can change too. That is why it helps to check a product's current status directly with the FDA's public information and with your provider, rather than relying on a clinic's advertising alone.

The right independent doctor may help you sort through the claims. A good visit generally starts with your health history, your goals, and an evaluation. A thoughtful provider will talk about a range of options, including ones that are not regenerative, and will be honest about what is known and unknown.

A provider can also explain a product's regulatory status in plain language. This may include whether it is FDA-approved, whether it is being studied under an FDA-reviewed process, or whether it is not approved for the use being discussed. No provider can promise a result.

Before considering any treatment, consider asking: Is this product FDA-approved for this use, or is it unapproved or research-use-only? Where does it come from, and how is it processed? Does it contain living cells? What are the risks? What are the alternatives? What is the total cost, including follow-up visits? Writing the answers down can make it easier to compare.